glp-1 substance use disorder medications get at the heart of addiction: study – WashU Medicine GLP-1 receptor agonists show promise

It is important that people who are prescribed GLP-1 analogues continue to take them and contact their diabetes team if they have any concerns. References [1] US Food and Drug Adminstration

Dose does not change the price the rate is flat across strengths, which simplifies comparison but folds titration into a single number

Its often the first peptide beginners try due to its strong safety profile and ease of administration

Obesity is a wellestablished risk factor for AFib and is associated with poorer outcomes following catheter ablation

SUSTAIN-6 documented absolute rates of 3.0% for retinopathy complications with semaglutide versus 1.8% with placebo

Schmitt V, Rink L, Uciechowski P